- Home
- Equipment
- canada british columbia
- pharmaceutics
Show results for
Refine by
Pharmaceutics Equipment Supplied In Canada British Columbia
19 equipment items found
Manufactured by:Phyton Biotech Ltd based inDelta, BRITISH COLUMBIA (CANADA)
Paclitaxel (sold under trade name Taxol® by Bristol-Myers Squibb) is a very effective plant-derived chemotherapy drug used to treat breast, ovarian, lung, bladder, prostate, melanoma, esophageal, as well as other types of solid tumor cancers. It has also been used to treat Kaposi’s sarcoma. ...
Manufactured by:Cryopak based inAnjou, QUEBEC (CANADA)
Cryopak Elite Gel Packs are a cost-effective way to safely transport items within the cold chain. Ideal for the pharmaceutical and food industries, these packs will help your products maintain their required storage temperatures during ...
Manufactured by:Phyton Biotech Ltd based inDelta, BRITISH COLUMBIA (CANADA)
Docetaxel (sold under trade name Taxotere) is a very effective plant-derived chemotherapy drug used to treat various cancers, including breast, lung, prostate, gastric, head and neck, and ovarian ...
Manufactured by:InMed Pharmaceuticals Inc. based inVancouver, BRITISH COLUMBIA (CANADA)
INM-088 is a topical eye drop formulation under development for the treatment of glaucoma. The active pharmaceutical ingredient (API) in INM-088 is cannabinol, also known as CBN, a rare cannabinoid showing promise in its potential to provide neuroprotection and to reduce intraocular pressure of the ...
Manufactured by:InMed Pharmaceuticals Inc. based inVancouver, BRITISH COLUMBIA (CANADA)
INM-755 is a cannabinol topical cream under development for the treatment of epidermolysis bullosa. INM-755 cream for EB is the first, and currently the only, cannabinol formulation being tested in clinical trials as a therapeutic ...
Manufactured by:InMed Pharmaceuticals Inc. based inVancouver, BRITISH COLUMBIA (CANADA)
Our subsidiary, BayMedica, is a B2B supplier of highly pure, premium bioidentical rare cannabinoids as raw ingredients for health and wellness products. BayMedica has been able to reliably manufacture rare, minor cannabinoids that are bioidentical to those found in the plant. This means that our cannabinoids have an identical molecular structure to the cannabinoids found in the Cannabis ...
Manufactured by:InMed Pharmaceuticals Inc. based inVancouver, BRITISH COLUMBIA (CANADA)
IntegraSyn is InMed’s integrated cannabinoid synthesis system to manufacture pharmaceutical-grade cannabinoids. Our goal has always been to achieve an efficient, scalable, flexible and economical solution to produce cannabinoids with bio-identical structures to those found in nature. IntegraSyn™ is designed to produce rare cannabinoids for ...
Manufactured by:Phyton Biotech Ltd based inDelta, BRITISH COLUMBIA (CANADA)
Phyton Biotech develops and applies sustainable and “green” chemistry manufacturing solutions for phytochemicals using PCF®, serving the Pharmaceutical, Traditional Chinese Medicine (TCM), Cosmetic, Agricultural and Food Ingredient ...
Manufactured by:Eupraxia Pharmaceuticals based inVictoria, BRITISH COLUMBIA (CANADA)
Many drugs have the potential to work well but are limited by the way they are delivered. This can lead to unwanted side effects, poor efficacy and a short duration of action. Eupraxia’s polymer-based proprietary technology aims to provide better therapy by delivering the right dose of drug, in the right place and for the right amount of ...
Manufactured by:Eupraxia Pharmaceuticals based inVictoria, BRITISH COLUMBIA (CANADA)
Eupraxia’s lead product candidate, EP-104IAR, is designed to meet the significant unmet medical need and market demand for long-lasting pain relief for knee osteoarthritis ...
Manufactured by:Eupraxia Pharmaceuticals based inVictoria, BRITISH COLUMBIA (CANADA)
Our patented technology is designed to be tailored to a wide variety of drugs and therapeutic indications. In addition to our lead drug candidate (EP-104IAR), Eupraxia is currently developing an extended-release post-surgical anesthetic (EP-105) and antibiotic (EP-201). Eupraxia hopes to add 1-2 additional candidates to our pipeline within the next year, including an internally developed oncology ...
Manufactured by:Aurora Biomed Inc. based inVancouver, BRITISH COLUMBIA (CANADA)
Cell-based assays have always been a powerful tool in biological research laboratories. Recently, cell-based assays have become preferred over traditional biochemical assays by both the pharmaceutical and biotech industry because they provide a more in vivo-like environment for biochemical experiments. However, such assays demand special methods and techniques that are not easily ...
Manufactured by:Aurinia Pharmaceuticals Inc. based inVictoria, BRITISH COLUMBIA (CANADA)
AUR200 is a recombinant Fc fusion protein designed to specifically block B-cell Activating Factor, known as BAFF, and A Proliferation-Inducing Ligand, known as APRIL. BAFF and APRIL promote B cell survival and differentiation and have been shown to play a prominent role in the pathogenesis of certain autoimmune and nephrology conditions. AUR200 is currently undergoing pre-clinical development ...
Manufactured by:Aurinia Pharmaceuticals Inc. based inVictoria, BRITISH COLUMBIA (CANADA)
AUR300 is a novel peptide therapeutic that modulates M2 macrophages (a type of white blood cells) via the macrophage mannose receptor CD206. Dysregulation of M2 macrophages drives fibrosis. AUR300 acts to reduce M2 dysregulation and decrease inflammatory cytokines, and therefore may have significant clinical applications for autoimmune and fibrotic diseases. It is anticipated that clinical ...
Manufactured by:Solarvest BioEnergy Inc. based inSummerville, PRINCE EDWARD ISLAND (CANADA)
The Company has promising laboratory results in hand for our first mid-term target, the expression of therapeutic proteins in algae. The company has used its proprietary technology to produce the highest published amounts of therapeutic proteins from algae, and is using this technology to produce Bone Morphogenetic Protein (BMP). BMP is applied during orthopedic surgery to fractures to accelerate ...
Manufactured by:Acuitas Therapeutics based inVancouver, BRITISH COLUMBIA (CANADA)
Acuitas specializes in the development of lipid nanoparticle delivery systems for molecular therapeutics. Our scientists have synthesized over 500 novel cationic lipids which have been evaluated in in vivo models including non-human primate (NHP) models. This evaluation characterizes the potency and safety of these LNP carriers for delivery of nucleic acid payloads including siRNA, mRNA, ...
Manufactured by:RepliCel Life Sciences based inVancouver, BRITISH COLUMBIA (CANADA)
RCH-01 is a proprietary autologous cell therapy being developed to treat pattern baldness.* *This product is currently in clinical testing and not yet commercially available. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. Though several cell types are involved, dermal sheath cup cells, located at base of ...
Manufactured by:Fusion Genomics Corporation based inBurnaby, BRITISH COLUMBIA (CANADA)
The goal of personalized medicine is to achieve optimal therapy for each patient based on his or her genomic profile. In infectious or host-dependent diseases, this means therapies that also take into account the pathogen’s mutating ...
Manufactured by:Sepset Biosciences Inc. based inVictoria, BRITISH COLUMBIA (CANADA)
Sepset is developing a blood test for hospitals to identify septic patients in the emergency room (ER) and predict those who will have high risk for organ ...